Publicaciones en las que colabora con Miguel Ángel Martínez González (10)

2023

  1. Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome

    Biomedicine and Pharmacotherapy, Vol. 161

  2. Corrigendum: Role of NAFLD on the health related QoL response to lifestyle in patients with metabolic syndrome: The PREDIMED plus cohort(Front. Endocrinol., (2022), 13, (868795), 10.3389/fendo.2022.868795)

    Frontiers in Endocrinology

  3. Dietary Iron, Anemia Markers, Cognition, and Quality of Life in Older Community-Dwelling Subjects at High Cardiovascular Risk

    Nutrients, Vol. 15, Núm. 20

2022

  1. Morbid liver manifestations are intrinsically bound to metabolic syndrome and nutrient intake based on a machine-learning cluster analysis

    Frontiers in Endocrinology, Vol. 13

  2. Role of NAFLD on the Health Related QoL Response to Lifestyle in Patients With Metabolic Syndrome: The PREDIMED Plus Cohort

    Frontiers in Endocrinology, Vol. 13

2021

  1. A Mediterranean lifestyle reduces the risk of cardiovascular disease in the “Seguimiento Universidad de Navarra” (SUN) cohort

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 31, Núm. 6, pp. 1728-1737

2002

  1. Dietary intake of n-3 fatty acids and the risk of acute myocardial infarction: A case-control study

    Medicina Clinica, Vol. 118, Núm. 4, pp. 121-125

1998

  1. Erratum: Prognosis of hepatocellular carcinoma in relation to treatment: A multivariate analysis of 178 patients from a single European institution (Surgery (1998) 124 (575-583))

    Surgery

  2. Prognosis of hepatocellular carcinoma i relation to treatment: A multivariate analysis of 178 patients from a single european institution

    Surgery, Vol. 124, Núm. 3, pp. 575-583

1997

  1. Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C

    Gastroenterology, Vol. 113, Núm. 5, pp. 1647-1653